The cervical microbiota of Hispanics living in Puerto Rico is nonoptimal regardless of HPV status

ABSTRACT The cervicovaginal microbiota is influenced by host physiology, immunology, lifestyle, and ethnicity. We hypothesized that there would be differences in the cervicovaginal microbiota among pregnant, nonpregnant, and menopausal women living in Puerto Rico (PR) with and without human papillomavirus (HPV) infection and cervical cancer. We specifically wanted to determine if the microbiota is associated with variations in cervical cytology. A total of 294 women, including reproductive-age nonpregnant (N = 196), pregnant (N = 37), and menopausal (N = 61) women, were enrolled. The cervicovaginal bacteria were characterized by 16S rRNA amplicon sequencing, the HPV was genotyped with SPF10-LiPA, and cervical cytology was quantified. High-risk HPV (HR-HPV, 67.3%) was prevalent, including genotypes not covered by the 9vt HPV vaccine. Cervical lesions (34%) were also common. The cervical microbiota was dominated by Lactobacillus iners. Pregnant women in the second and third trimesters exhibited a decrease in diversity and abundance of microbes associated with bacterial vaginosis. Women in menopause had greater alpha diversity, a greater proportion of facultative and strictly anaerobic bacteria, and higher cervicovaginal pH than premenopausal women. Cervical lesions were associated with greater alpha diversity. However, no significant associations between the microbiota and HPV infection (HR or LR-HPV types) were found. The cervicovaginal microbiota of women living in Puerto Rican were either dominated by L. iners or diverse microbial communities regardless of a woman’s physiological stage. We postulate that the microbiota and the high prevalence of HR-HPV increase the risk of cervical lesions among women living in PR. IMPORTANCE In the enclosed manuscript, we provide the first in-depth characterization of the cervicovaginal microbiota of Hispanic women living in Puerto Rico (PR), using a 16S rRNA approach, and include women of different physiological stages. Surprisingly we found that high-risk HPV was ubiquitous with a prevalence of 67.3%, including types not covered by the 9vt HPV vaccine. We also found highly diverse microbial communities across women groups—with a reduction in pregnant women, but dominated by nonoptimal Lactobacillus iners. Additionally, we found vaginosis-associated bacteria as Dialister spp., Gardnerella spp., Clostridium, or Prevotella among most women. We believe this is a relevant and timely article expanding knowledge on the cervicovaginal microbiome of PR women, where we postulate that these highly diverse communities are conducive to cervical disease. In the enclosed manuscript, we provide the first in-depth characterization of the cervicovaginal microbiota of Hispanic women living in Puerto Rico (PR), using a 16S rRNA approach, and include women of different physiological stages. Surprisingly we found that high-risk HPV was ubiquitous with a prevalence of 67.3%, including types not covered by the 9vt HPV vaccine. We also found highly diverse microbial communities across women groups—with a reduction in pregnant women, but dominated by nonoptimal Lactobacillus iners. Additionally, we found vaginosis-associated bacteria as Dialister spp., Gardnerella spp., Clostridium, or Prevotella among most women. We believe this is a relevant and timely article expanding knowledge on the cervicovaginal microbiome of PR women, where we postulate that these highly diverse communities are conducive to cervical disease.

[1]  J. Gilbert,et al.  The effects of hormone replacement therapy on the microbiomes of postmenopausal women , 2023, Climacteric : the journal of the International Menopause Society.

[2]  Junhyung Park,et al.  Transition in vaginal Lactobacillus species during pregnancy and prediction of preterm birth in Korean women , 2022, Scientific reports.

[3]  R. Burk,et al.  molBV reveals immune landscape of bacterial vaginosis and predicts human papillomavirus infection natural history , 2022, Nature communications.

[4]  H. Verstraelen,et al.  The Vaginal Microbiome: II. Vaginal Dysbiotic Conditions , 2021, Journal of lower genital tract disease.

[5]  Ruber Rodríguez-Barreras,et al.  Trophic niches reflect compositional differences in microbiota among Caribbean sea urchins , 2021, PeerJ.

[6]  D. Ercolini,et al.  The Vaginal Microbiome: A Long Urogenital Colonization Throughout Woman Life , 2021, Frontiers in Cellular and Infection Microbiology.

[7]  K. Nelson,et al.  The cervicovaginal microbiome and its resistome in a random selection of Afro-Caribbean women , 2021 .

[8]  Timothy L. Tickle,et al.  Multivariable association discovery in population-scale meta-omics studies , 2021, bioRxiv.

[9]  G. Tortolero-Luna,et al.  Incidence of Cervical Cancer in Puerto Rico, 2001-2017. , 2021, JAMA oncology.

[10]  Stephanie L. Rager,et al.  Maternal Microbiome and Infections in Pregnancy , 2020, Microorganisms.

[11]  Xiaofeng Mu,et al.  Cervicovaginal microbiota dysbiosis correlates with HPV persistent infection. , 2020, Microbial pathogenesis.

[12]  J. Ravel,et al.  Changes in the vaginal microbiota across a gradient of urbanization , 2020, Scientific Reports.

[13]  Wenjing Wang,et al.  Human papillomavirus infection and cervical intraepithelial neoplasia progression are associated with increased vaginal microbiome diversity in a Chinese cohort , 2020, BMC Infectious Diseases.

[14]  J. Oksanen,et al.  The green view dataset for the capital of Finland, Helsinki , 2020, Data in brief.

[15]  M. Dominguez-Bello,et al.  An in-depth survey of the microbial landscape of the walls of a neonatal operating room , 2020, PloS one.

[16]  P. Castle,et al.  Cervicovaginal microbiome and natural history of HPV in a longitudinal study , 2020, PLoS pathogens.

[17]  P. Gajer,et al.  VALENCIA: a nearest centroid classification method for vaginal microbial communities based on composition , 2020, Microbiome.

[18]  W. C. Beck,et al.  Package. , 2020, Surgery, gynecology & obstetrics.

[19]  J. Romaguera,et al.  Cervicovaginal Microbiome and Urine Metabolome Paired Analysis Reveals Niche Partitioning of the Microbiota in Patients with Human Papilloma Virus Infections , 2020, Metabolites.

[20]  L. Engstrand,et al.  The vaginal microbiota, human papillomavirus and cervical dysplasia: a systematic review and network meta‐analysis , 2019, BJOG : an international journal of obstetrics and gynaecology.

[21]  Jacques Ferlay,et al.  Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis , 2019, The Lancet. Global health.

[22]  S. Kovachev Cervical cancer and vaginal microbiota changes , 2019, Archives of Microbiology.

[23]  Yunshan Wang,et al.  Patients With LR-HPV Infection Have a Distinct Vaginal Microbiota in Comparison With Healthy Controls , 2019, Front. Cell. Infect. Microbiol..

[24]  Hardik I. Parikh,et al.  Racioethnic diversity in the dynamics of the vaginal microbiome during pregnancy , 2019, Nature Medicine.

[25]  Denise J. Roe,et al.  Deciphering the complex interplay between microbiota, HPV, inflammation and cancer through cervicovaginal metabolic profiling , 2019, EBioMedicine.

[26]  Christopher M. Taylor,et al.  In Silico and Experimental Evaluation of Primer Sets for Species-Level Resolution of the Vaginal Microbiota Using 16S Ribosomal RNA Gene Sequencing , 2018, The Journal of infectious diseases.

[27]  Youzhong Zhang,et al.  Involvement of Human Papillomaviruses in Cervical Cancer , 2018, Front. Microbiol..

[28]  Jacques Ravel,et al.  Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy , 2018, Menopause.

[29]  M. Blaser,et al.  Cervicovaginal Fungi and Bacteria Associated With Cervical Intraepithelial Neoplasia and High-Risk Human Papillomavirus Infections in a Hispanic Population , 2018, Front. Microbiol..

[30]  Mingxun Wang,et al.  Qiita: rapid, web-enabled microbiome meta-analysis , 2018, Nature Methods.

[31]  S. Syrjänen,et al.  HPV infection and bacterial microbiota in the placenta, uterine cervix and oral mucosa , 2018, Scientific Reports.

[32]  D. Anumba,et al.  The Vaginal Microenvironment: The Physiologic Role of Lactobacilli , 2018, Front. Med..

[33]  Benjamin D. Kaehler,et al.  Optimizing taxonomic classification of marker-gene amplicon sequences with QIIME 2’s q2-feature-classifier plugin , 2018, Microbiome.

[34]  L. Forney,et al.  High Rate of Infection by Only Oncogenic Human Papillomavirus in Amerindians , 2018, mSphere.

[35]  J. Palefsky,et al.  Seroprevalence of HPV 6, 11, 16 and 18 and correlates of exposure in unvaccinated women aged 16–64 years in Puerto Rico , 2018, Papillomavirus research.

[36]  Benjamin D. Kaehler,et al.  Optimizing taxonomic classification of marker-gene amplicon sequences with QIIME 2’s q2-feature-classifier plugin , 2018, Microbiome.

[37]  Per B. Brockhoff,et al.  lmerTest Package: Tests in Linear Mixed Effects Models , 2017 .

[38]  Marti J. Anderson,et al.  Permutational Multivariate Analysis of Variance (PERMANOVA) , 2017 .

[39]  J. Ravel,et al.  Lactobacillus iners-dominated vaginal microbiota is associated with increased susceptibility to Chlamydia trachomatis infection in Dutch women: a case–control study , 2017, Sexually Transmitted Infections.

[40]  D. Cavalieri,et al.  Characterization of cervico-vaginal microbiota in women developing persistent high-risk Human Papillomavirus infection , 2017, Scientific Reports.

[41]  D. Money,et al.  The vaginal microbiome of pregnant women is less rich and diverse, with lower prevalence of Mollicutes, compared to non-pregnant women , 2017, Scientific Reports.

[42]  C. Adebamowo,et al.  Mycoplasma hominis and Mycoplasma genitalium in the Vaginal Microbiota and Persistent High-Risk Human Papillomavirus Infection , 2017, Front. Public Health.

[43]  R. Knight,et al.  Bacterial Community Composition and Dynamics Spanning Five Years in Freshwater Bog Lakes , 2017, mSphere.

[44]  Gregory A. Buck,et al.  Changes in vaginal community state types reflect major shifts in the microbiome , 2017, Microbial ecology in health and disease.

[45]  P. Gajer,et al.  Association of HPV infection and clearance with cervicovaginal immunology and the vaginal microbiota , 2016, Mucosal Immunology.

[46]  M. Herbst-Kralovetz,et al.  Menopause and the vaginal microbiome. , 2016, Maturitas.

[47]  Julie K. Pfeiffer,et al.  Host response: Microbiota prime antiviral response , 2016, Nature Microbiology.

[48]  J. K. Nicholson,et al.  Cervical intraepithelial neoplasia disease progression is associated with increased vaginal microbiome diversity , 2015, Scientific Reports.

[49]  J. Palmgren,et al.  Interactions Between High- and Low-Risk HPV Types Reduce the Risk of Squamous Cervical Cancer. , 2015, Journal of the National Cancer Institute.

[50]  K. Agnew,et al.  Hydrogen Peroxide–Producing Lactobacilli Are Associated With Lower Levels of Vaginal Interleukin-1&bgr;, Independent of Bacterial Vaginosis , 2015, Sexually transmitted diseases.

[51]  G. Simpson,et al.  Functions for Generating Restricted Permutations of Data , 2015 .

[52]  Melis N. Anahtar,et al.  Cervicovaginal bacteria are a major modulator of host inflammatory responses in the female genital tract. , 2015, Immunity.

[53]  Yan He,et al.  Homogeneity of the Vaginal Microbiome at the Cervix, Posterior Fornix, and Vaginal Canal in Pregnant Chinese Women , 2015, Microbial Ecology.

[54]  David Reich,et al.  The Genetic Ancestry of African Americans, Latinos, and European Americans across the United States , 2015, American journal of human genetics.

[55]  Mardge H. Cohen,et al.  Free Glycogen in Vaginal Fluids Is Associated with Lactobacillus Colonization and Low Vaginal pH , 2014, PloS one.

[56]  P. Gajer,et al.  Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy , 2014, Menopause.

[57]  Ronald W. Davis,et al.  Diversity of the Vaginal Microbiome Correlates With Preterm Birth , 2014, Reproductive Sciences.

[58]  Jacques Ravel,et al.  Daily temporal dynamics of vaginal microbiota before, during and after episodes of bacterial vaginosis , 2013, Microbiome.

[59]  R. Cone,et al.  Vaginal pH and Microbicidal Lactic Acid When Lactobacilli Dominate the Microbiota , 2013, PloS one.

[60]  R. Schwabe,et al.  The Microbiome and Cancer , 2021, Gut Feelings.

[61]  A. Moscicki,et al.  Revised terminology for cervical histopathology and its implications for management of high-grade squamous intraepithelial lesions of the cervix. , 2012, Obstetrics and gynecology.

[62]  Zaid Abdo,et al.  Temporal Dynamics of the Human Vaginal Microbiota , 2012, Science Translational Medicine.

[63]  William A. Walters,et al.  Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms , 2012, The ISME Journal.

[64]  Joel s. Brown,et al.  Evolutionary ecology of human papillomavirus: trade-offs, coexistence, and origins of high-risk and low-risk types. , 2012, The Journal of infectious diseases.

[65]  W. Ledger,et al.  Influence of Lactic Acid on Endogenous and Viral RNA-Induced Immune Mediator Production by Vaginal Epithelial Cells , 2011, Obstetrics and gynecology.

[66]  H. Yoshikawa,et al.  Prevalence and type distribution of human papillomavirus in healthy Japanese women aged 20 to 25 years old enrolled in a clinical study , 2011, Cancer science.

[67]  Christopher R. Gignoux,et al.  History Shaped the Geographic Distribution of Genomic Admixture on the Island of Puerto Rico , 2011, PloS one.

[68]  Fang Liu,et al.  Molecular analysis of the diversity of vaginal microbiota associated with bacterial vaginosis , 2010, BMC Genomics.

[69]  P. Gajer,et al.  Vaginal microbiome of reproductive-age women , 2010, Proceedings of the National Academy of Sciences.

[70]  Lu Wang,et al.  The NIH Human Microbiome Project. , 2009, Genome research.

[71]  T. Van den Bosch,et al.  Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy , 2009, BJOG : an international journal of obstetrics and gynaecology.

[72]  J. Archambault,et al.  Molecular Mechanisms of Human Papillomavirus-Induced Carcinogenesis , 2009, Public Health Genomics.

[73]  Eduardo Barrientos,et al.  Analysis of genomic diversity in Mexican Mestizo populations to develop genomic medicine in Mexico , 2009, Proceedings of the National Academy of Sciences.

[74]  Sandra Tscherwizek 16s Ribosomal RNA Gene Sequencing , 2008 .

[75]  W. Quint,et al.  Sexual Behaviour and HPV Infections in 18 to 29 Year Old Women in the Pre-Vaccine Era in the Netherlands , 2008, PloS one.

[76]  W. Quint,et al.  Comparison of the SPF10-LiPA System to the Hybrid Capture 2 Assay for Detection of Carcinogenic Human Papillomavirus Genotypes among 5,683 Young Women in Guanacaste, Costa Rica , 2007, Journal of Clinical Microbiology.

[77]  J. Marrazzo,et al.  Molecular identification of bacteria associated with bacterial vaginosis. , 2005, The New England journal of medicine.

[78]  B. Crothers The Bethesda System 2001: Update on Terminology and Application , 2005, Clinical obstetrics and gynecology.

[79]  M. Sherman,et al.  An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[80]  K. Whaley,et al.  Origins of vaginal acidity: high D/L lactate ratio is consistent with bacteria being the primary source. , 2001, Human reproduction.

[81]  S. Hillier,et al.  The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species. , 1999, The Journal of infectious diseases.

[82]  J. Dillner,et al.  Serological evidence for protection by human papillomavirus (HPV) type 6 infection against HPV type 16 cervical carcinogenesis. , 1999, The Journal of general virology.

[83]  T. Bjørge,et al.  No excess risk of cervical carcinoma among women seropositive for both HPV16 and HPV6/11 , 1999, International journal of cancer.

[84]  J. Orenstein,et al.  Secretory leukocyte protease inhibitor (SLPI) in mucosal fluids inhibits HIV‐1 , 1997 .

[85]  Mary Frances Cotch,et al.  Association between Bacterial Vaginosis and Preterm Delivery of a Low-Birth-Weight Infant , 1995 .

[86]  S. R. Searle,et al.  Population Marginal Means in the Linear Model: An Alternative to Least Squares Means , 1980 .

[87]  R. Cruickshank The conversion of the glycogen of the vagina into lactic acid , 1934 .